Clinical infection medicine
101 – 110 of 169
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Probiotics for intestinal decolonization of ESBL-producing enterobacteriaceae; a randomized, placebo-controlled clinical trial
(
- Contribution to journal › Article
-
Mark
HIV treatment in Guinea-Bissau : room for improvement and time for new treatment options
(
- Contribution to journal › Scientific review
-
Mark
Distribution of HLA-DQ risk genotypes for celiac disease in Ethiopian children
(
- Contribution to journal › Article
-
Mark
A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection
(
- Contribution to journal › Article
-
Mark
Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results
(
- Contribution to journal › Article
-
Mark
Association of acute myocardial infarction with influenza : A nationwide observational study
(
- Contribution to journal › Article
-
Mark
Management of an outbreak of postpartum Streptococcus pyogenes emm75 infections
(
- Contribution to journal › Article
-
Mark
Brief Report : Interferon-γ-Inducible Protein 10-A Potential Marker for Targeted Viral Load Monitoring of Antiretroviral Treatment?
(
- Contribution to journal › Article
-
Mark
Age and sex differences in soluble ACE2 may give insights for COVID-19
(
- Contribution to journal › Letter
-
Mark
Improved Outcomes After Regional Implementation of Sepsis Alert : A Novel Triage Model
(
- Contribution to journal › Article